Ercros, S.A. (BME: ECR)

Market Cap	343.80M
Revenue (ttm)	657.22M
Net Income (ttm)	12.44M
Shares Out	91.44M
EPS (ttm)	0.14
PE Ratio	27.50
Forward PE	39.58
Dividend	0.10 (2.55%)
Ex-Dividend Date	Jul 8, 2024

Volume	41,013
Open	3.770
Previous Close	3.760
Day's Range	3.745 - 3.770
52-Week Range	2.260 - 3.980
Beta	0.75
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 15, 2024

About Ercros

Ercros, S.A. manufactures and sells basic chemicals, intermediate chemicals, and pharmaceuticals in Spain. It operates through three segments: Chlorine Derivatives, Intermediate Chemicals, and Pharmacy. The Chlorine Derivatives segment produces ammonia, bioplastics, caustic potash and soda, chlorine, chloroisocyanurates, dicalcium phosphate, dichloroethane, hydrochloric acid, hydrogen peroxide, potassium carbonate, PVC compounds, sodium chlorate and chlorite, sodium hypochlorite, and vinyl chloride monomers and polychloride. This segment’s prod...

• Industry: Chemicals
• Sector: Materials
• Founded: 1817
• Employees: 1,359
• Stock Exchange: Madrid Stock Exchange
• Ticker Symbol: ECR

Financial Performance

In 2023, PRS's revenue was 945.65 million, an increase of 11.53% compared to the previous year's 847.90 million. Losses were -32.51 million, 151.0% more than in 2022.